Use of Regional Anesthesia in Hip Arthroscopy
- Conditions
- Hip Injuries
- Interventions
- Registration Number
- NCT02851888
- Lead Sponsor
- Georgetown University
- Brief Summary
The purpose of this research is to determine differences in outcomes in patients who do, or do not, receive regional anesthesia (a fascia iliaca block) prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement
- Detailed Description
Patients undergoing hip arthroscopy for hip impingement at the investigator's institution often have regional anesthesia (a nerve block) prior to the procedure to help prevent and/or reduce pain following the procedure. The investigators are interested in determining benefits as well as potential adverse effects of utilizing regional anesthesia in patients undergoing hip arthroscopy for impingement. To do so, they plan to enroll patients aged 18-50 undergoing hip arthroscopy, and randomize them to one of two groups with one group receiving regional anesthesia pre-operatively and the second control group, that does not. The surgical procedure and the post-operative management will be the same for both groups.
Regional anesthesia prior to orthopaedic procedures has been widely adopted in many fields of orthopaedics. While it is generally considered safe and an excellent adjuvant for pain control, there have been few studies exploring outcomes beyond pain control. In many centers, the use of regional anesthesia in hip arthroscopy is reserved for post-operative management of pain. There are multiple studies indicating that patients receiving regional anesthesia (a fascia iliaca or femoral nerve block) had significantly greater improvements in pain score and even an excellent alternative to routine narcotic medication in patients undergoing hip arthroscopy. Other orthopaedic procedures, such as knee arthroscopy, utilize similar techniques to achieve post-operative pain control through a femoral-sciatic nerve block.
There have also been studies looking at the utilization of regional anesthesia via lumbar plexus blocks with hip arthroscopy. One study found that patients undergoing hip arthroscopy with higher levels of preoperative psychological distress frequently utilized a lumbar plexus block to achieve adequate pain control. Other studies found that lumbar plexus blocks significantly improved pain while in the PACU. While serious complications of lumbar plexus block were rare, minor complications such as falls, persistent paresthesias, and unexpected admissions do occur. At our institution, we do not utilize lumbar plexus blocks for regional anesthesia in patients undergoing hip arthroscopy. Rather, our standard of care is to have an anesthesiologist perform a single shot fascia iliaca block using ropivicaine while the patient is in the pre-operative holding bay.
To the investigative team's knowledge, there are no studies comparing the difference in pain control, as well as the differences in narcotic requirements in PACU, duration of stay in PACU, reported falls, unplanned admissions and/or readmissions, Harris hip score and nerve pain/paresthesias/numbness in patients who have undergone hip arthroscopy with and without regional anesthesia. A better understanding of pain and functional outcomes following hip arthroscopy with and without regional anesthesia can help providers better assess circumstances when regional anesthesia can be beneficial or detrimental to a patient's post-operative course.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 70
- Scheduled for arthroscopic labral repair with or without osteoplasty of the hip.
- 18 to 50 years old
- American Society of Anesthesiologists Physical Status (ASA PS) score of I or II.
- Current or planned pregnancy
- History of neuropathic pain, chronic pain syndrome, or preoperative use of narcotic or neuropathic pain medicine
- Radiographic signs of osteoarthritis (> Tonis grade 1)
- Inability to attend follow up visits
- Documented allergy to local anesthetic
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Iliac Fascia Block (Ropivacaine) General Anesthesia These patients will receive a preoperative iliac fascia block performed as a single shot in the standard fashion prior to hip arthroscopy with general anesthesia. Control (Normal Saline Sham Injection) Normal Saline Sham Injection These patients will receive a preoperative sham block of normal saline in the same fashion as a standard singl shot iliac fascia block prior to hip arthroscopy with general anesthesia. Control (Normal Saline Sham Injection) General Anesthesia These patients will receive a preoperative sham block of normal saline in the same fashion as a standard singl shot iliac fascia block prior to hip arthroscopy with general anesthesia. Iliac Fascia Block (Ropivacaine) Ropivacaine These patients will receive a preoperative iliac fascia block performed as a single shot in the standard fashion prior to hip arthroscopy with general anesthesia.
- Primary Outcome Measures
Name Time Method Pain Medication Requirement in PACU 24 hours post-operatively Measured in morphine equivalents
- Secondary Outcome Measures
Name Time Method Duration of PACU stay (mins) 24 hours post-operatively time from PACU admission to discharge
Visual Analogue Pain Scores (VAS) 24 hours post-operatively patient reported
Falls 6 weeks patient reported
Neuropathic Pain 2 weeks and 6 weeks Self Reported- Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaires will be completed at both 2 and 6 week follow-up
Readmissions 6 weeks patient reported and through chart review
Time to Physical Therapy 6 weeks patient reported
Long Term Pain Control (daily VAS record) 6 weeks Patients will complete a daily VAS questionnaire at home
Modified Harris hip score 6 weeks Questionnaire administered at 6 week follow up to evaluate functional outcomes
Long Term Medication Requirements (daily log of medication usage in tablets of 5 mg oxycodone, morphine extended relief 15 mg, and/or indomethacin 75 mg) 6 weeks Patients will complete a daily medication log at home
Trial Locations
- Locations (1)
Georgetown University Medical Center
🇺🇸Washington, District of Columbia, United States